Dostinex 0.5mg - 8 Tablets
Cabergoline" tablets used to lower high levels of prolactin hormone (hyperprolactinemia). It treats menstrual irregularities, fertility issues in both genders, and is used to medically stop milk production when necessary.

To get online prescription you can take an online consultation
Quantity
Free shipping on all orders over99

Home Delivery or Pickup
- Key IngredientsCabergoline 0.5mg
- Product FormTablets
- Package Size8 Tablets
- Caution & WarningsDo not use for patients with severe hepatic impairment or those with a history of heart valve issues. Periodic cardiac function tests are required during long-term treatment.
- Storage ConditionsStore at room temperature (below 25°C) in a dry place. Keep the bottle tightly closed to protect the tablets from moisture.
- How To UseTaken orally, usually once or twice a week as prescribed by your doctor. It is preferred to take it with food to minimize nausea.
- ConcernsHormonal Balance & Fertility Management
-
What is the primary use of Dostinex?
-
Answer: Dostinex is used to treat high levels of the hormone prolactin, which can cause fertility issues, menstrual irregularities, or abnormal milk production.
-
-
How does Dostinex work in the body?
-
Answer: It contains the active ingredient "Cabergoline," which stimulates dopamine receptors in the pituitary gland, leading to a decrease in prolactin secretion.
-
-
Why is it taken only once or twice a week?
-
Answer: Dostinex has a long-lasting effect that remains in the body for a significant time, so it doesn't need to be taken daily; instead, it's taken at spaced intervals as directed by a doctor.
-
-
When should the dose be taken to minimize side effects?
-
Answer: It is best to take the dose with food and right before bedtime to reduce symptoms like dizziness or nausea that may occur initially.
-
-
Does Dostinex help in cases of delayed pregnancy?
-
Answer: Yes, if delayed pregnancy is caused by high prolactin levels inhibiting ovulation, regulating the hormone helps restore normal ovulation.
-





